secwatch.observer — SEC 8-K summary
======================================

Issuer:     MIMEDX GROUP, INC. (MDXG)
CIK:        0001376339
Form:       8-K
Filed at:   2023-01-30T23:59:59+00:00
Accession:  0001193125-23-018383
Event type: leadership
Sentiment:  positive
Materiality: 0.75
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MiMedx appoints ex-BioTelemetry CEO Joseph H. Capper as CEO, effective Jan 27
-----------------------------------------------------------------------------

- Appointed Joseph H. Capper as CEO and director, effective Jan 27, 2023; Todd Newton steps down as interim CEO but remains on board.
- Capper receives $750k salary, 100% target bonus, 3.3M PSUs (4-yr vest), and option for 3.6M shares at $3.70 strike.
- Capper previously led BioTelemetry, acquired by Philips for $2.8B; has ~30 years MedTech/Life Sciences experience.
- Inducement PSUs and option granted outside equity plan under Nasdaq Rule 5635(c)(4).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1376339/000119312523018383/0001193125-23-018383-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1376339/000119312523018383/d456121d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-018383

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer